Alberto Bianchinotti

Director of Finance/CFO at LF CAPITAL ACQUISITION CORP. II

49 year

Finance

Commercial Services

Consumer Services

Profile

Alberto Bianchinotti is currently the Chief Financial Officer at Merlin Nexus and LF Capital Acquisition Corp.
II.
In the past, he worked as an Analyst at Merlin Biomed Group Hedge Funds and as a Supervisor at Anchin, Block & Anchin LLP.
He also served as the Chief Financial Officer at LF Capital Acquisition Corp.
Mr. Bianchinotti received his undergraduate degree from the State University of New York at Binghamton in 1999.

Alberto Bianchinotti active positions

Companies	Position	Start
LF CAPITAL ACQUISITION CORP. II	Director of Finance/CFO	2021-02-28
Merlin Nexus Merlin Nexus Investment ManagersFinance Merlin Nexus invests in both private and public life sciences companies across the globe. The firm focuses on sectors such as biotechnology, medical devices, molecular diagnostics, and specialty pharmaceuticals. It participates in late-stage and PIPE (Private Investments in Public Equity) transactions.	Director of Finance/CFO	2006-12-31

All active positions of Alberto Bianchinotti

Former positions of Alberto Bianchinotti

Companies	Position	End
Merlin Biomed Group Hedge Funds Merlin Biomed Group Hedge Funds Investment ManagersFinance Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs.	Analyst-Equity	2006-12-30
Anchin, Block & Anchin LLP Anchin, Block & Anchin LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax and advisory services	Corporate Officer/Principal	2004-06-29
LF CAPITAL ACQUISITION CORP.	Director of Finance/CFO	-

See the detail of Alberto Bianchinotti's experience

Training of Alberto Bianchinotti

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alberto Bianchinotti's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Merlin Biomed Group Hedge Funds Merlin Biomed Group Hedge Funds Investment ManagersFinance Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs.	Finance
Anchin, Block & Anchin LLP Anchin, Block & Anchin LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax and advisory services	Commercial Services
Merlin Nexus Merlin Nexus Investment ManagersFinance Merlin Nexus invests in both private and public life sciences companies across the globe. The firm focuses on sectors such as biotechnology, medical devices, molecular diagnostics, and specialty pharmaceuticals. It participates in late-stage and PIPE (Private Investments in Public Equity) transactions.	Finance
State University of New York at Binghamton State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LF Capital Acquisition Corp. LF Capital Acquisition Corp. Financial ConglomeratesFinance Provides investment services	Finance
LF Capital Acquisition Corp. II LF Capital Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company	Finance